Figure 6
From: Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer
Tissue expression of FGFR4 among prostate cancer participants. The intensity of immunoreactivity was mainly concentrated in the cytoplasm of prostate cancer epithelial cells (C,D). The expression of FGFR4 is up-regulated in more advanced cases (D), as compared to ones in early stage (A,B, P < 0.05).
